Reckitt beats quarterly like-for-like sales estimates

LONDON (Reuters) – Reckitt beat third-quarter like-for-like net sales growth estimates on Wednesday, helped by its health business, which makes Nurofen pain pills and Strepsils lozenges.

The company, owner of the Dettol and Lysol cleaning brands, said it was on track to meet full-year targets.

Reckitt’s quarterly like-for-like net sales fell 0.5%, ahead of the 1.7% decline analysts had expected in a company-supplied poll.

“Health delivered sequential improvement in the quarter and Hygiene delivered a solid quarter of growth despite a more competitive market backdrop in developed markets,” CEO Kris Licht said.